{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:06:12Z","timestamp":1793639172747,"version":"4.5.1"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.critrevonc.2021.103226","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T11:51:02Z","timestamp":1611057062000},"page":"103226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-699X","authenticated-orcid":false,"given":"Michael I.","family":"Koukourakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3706-8845","authenticated-orcid":false,"given":"Alexandra","family":"Giatromanolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2021.103226_bib0005","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2005-06-2399","article-title":"IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients","volume":"107","author":"Ahmadzadeh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.it.2004.11.002","article-title":"IL-7 and IL-15: therapeutic cytokines for immunodeficiency","volume":"26","author":"Alpdogan","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-3148.2000.00264.x","article-title":"Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan","volume":"10","author":"Asai","year":"2000","journal-title":"Transfus. Med."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-013-1164-9","article-title":"The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme","volume":"114","author":"Bambury","year":"2013","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0025","article-title":"The natural and induced resistance of mice to the growth of cancer","author":"Bashford","year":"1907","journal-title":"Proc. R. Soc. B"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0030","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.180.4092.1289","article-title":"Rejection of tumor cells in vitro","volume":"180","author":"Berczi","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0035","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1080\/10428194.2016.1262951","article-title":"Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patients","volume":"58","author":"Bhethanabhotla","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0040","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2017.07.027","article-title":"Prospective validation of a prognostic score for patients in immunotherapy phase I trials: the Gustave Roussy Immune Score (GRIm-Score)","volume":"84","author":"Bigot","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0145-2126(02)00051-6","article-title":"Amifostine differentially modulates DNA damage evoked by idarubicin in normal and leukemic cells","volume":"26","author":"B\u0142asiak","year":"2002","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0050","first-page":"839","article-title":"Impact of adjuvant chemotherapy on spontaneous and poke week mitogen triggered immunoglobulin secretion of blood lymphocytes in operable breast cancer","volume":"8","author":"Blomgren","year":"1988","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0065","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0070","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.136.6.1631","article-title":"Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor","volume":"136","author":"Brooks","year":"1972","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0075","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00066-019-01462-5","article-title":"Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma","volume":"195","author":"Byun","year":"2019","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0080","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/molecules13081759","article-title":"Amifostine protection against mitomycin-induced chromosomal breakage in fanconi anaemia lymphocytes","volume":"13","author":"Camelo","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0085","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00280-011-1610-3","article-title":"Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy","volume":"68","author":"C\u00e9z\u00e9","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","article-title":"Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy?","volume":"97","author":"Chadha","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0095","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.2147\/DDDT.S212610","article-title":"Baseline lymphopenia: a predictor of poor outcomes in HER2 positive metastatic breast cancer treated with trastuzumab","volume":"13","author":"Che","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2217\/imt.11.79","article-title":"Tregs in immunotherapy: opportunities and challenges","volume":"3","author":"Chen","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0105","article-title":"Absolute lymphocyte count predicts abscopal responses and outcomes in patients receiving combined immunotherapy and radiotherapy: a prospective-retrospective analysis of 3 phase I\/II trials","author":"Chen","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2020.05.051","article-title":"Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy","volume":"150","author":"Chen","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0115","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of treatment-related lymphopenia on immunotherapy for advanced non-small cell lung cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1200\/JCO.2014.57.3329","article-title":"Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer","volume":"33","author":"Conlon","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0125","first-page":"83","article-title":"Tumor escape from immune surveillance","volume":"47","author":"Costello","year":"1999","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40425-016-0149-6","article-title":"A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma","volume":"4","author":"Crocenzi","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0135","doi-asserted-by":"crossref","first-page":"114268","DOI":"10.18632\/oncotarget.23217","article-title":"Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors","volume":"8","author":"Diehl","year":"2017","journal-title":"Oncotarget"},{"issue":"December (12)","key":"10.1016\/j.critrevonc.2021.103226_bib0140","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1002\/eji.201444879","article-title":"Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis","volume":"44","author":"Dimeloe","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/eji.201646875","article-title":"Immune checkpoints and their inhibition in cancer and infectious diseases","volume":"47","author":"Dyck","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.adro.2018.08.014","article-title":"Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors","volume":"3","author":"Ellsworth","year":"2018","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived-suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0160","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","article-title":"Timing of rectal cancer response to chemoradiation consortium. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0165","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1200\/JCO.19.00934","article-title":"Five-year overall survival for patients with advanced non\u2012small-cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study","volume":"37","author":"Garon","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0170","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end-stage cancer patients","volume":"56","author":"Ghiringhelli","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12032-019-1299-4","article-title":"Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis","volume":"36","author":"Giatromanolaki","year":"2019","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/SPC.0b013e32832e4681","article-title":"Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma","volume":"3","author":"Guevremont","year":"2009","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2407-13-136","article-title":"Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study","volume":"13","author":"Guo","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0190","doi-asserted-by":"crossref","first-page":"873","DOI":"10.21873\/anticanres.14020","article-title":"Effects of alkalization therapy on chemotherapy outcomes in metastatic or recurrent pancreatic cancer","volume":"40","author":"Hamaguchi","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0195","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/1097-0142(197709)40:3<1102::AID-CNCR2820400319>3.0.CO;2-0","article-title":"Lymphopenia caused by cranial irradiation in children receiving craniospinal radiotherapy","volume":"40","author":"Harisiadis","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1200\/JCO.2000.18.1.148","article-title":"Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283","volume":"18","author":"Harris","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0205","first-page":"2597","article-title":"Human interleukin 2 analogs that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogs in cancer immunotherapy","volume":"53","author":"Heaton","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0210","first-page":"2597","article-title":"Human interleukin 2 analogs that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogs in cancer immunotherapy","volume":"53","author":"Heaton","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0215","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1158\/1078-0432.CCR-08-0338","article-title":"A phase I trial of pemetrexed plus gemcitabine, given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer","volume":"14","author":"Hensley","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0220","doi-asserted-by":"crossref","first-page":"e83384","DOI":"10.1371\/journal.pone.0083384","article-title":"Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response","volume":"8","author":"Heylmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0225","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s10637-010-9396-4","article-title":"Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I study","volume":"29","author":"Ho","year":"2011","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0230","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40425-018-0395-x","article-title":"Association between pre-treatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas","volume":"6","author":"Ho","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0235","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/jcm9051441","article-title":"Analysis of systemic inflammatory factors and survival outcomes in endometrial cancer patients staged I-III FIGO and treated with postoperative external radiotherapy","volume":"9","author":"Holub","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0240","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00262-018-2288-8","article-title":"The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial","volume":"68","author":"Huijts","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780180113","article-title":"The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases","volume":"18","author":"Hurd","year":"1975","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0250","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1158\/1078-0432.CCR-10-1757","article-title":"Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I\/II study in metastatic melanoma patients","volume":"16","author":"Jacobs","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0255","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/annonc\/mdv546","article-title":"Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer","volume":"27","author":"Joseph","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0260","first-page":"5191","article-title":"Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer","volume":"55","author":"Kaklamanis","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0265","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12094-018-1908-2","article-title":"The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study","volume":"21","author":"Karantanos","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(01)25621-9","article-title":"An attempt to produce immunity to malignant disease in man","volume":"5136","author":"Kellock","year":"1922","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0275","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1996.14.7.2101","article-title":"Amifostine pre-treatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer","volume":"14","author":"Kemp","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0280","first-page":"253","article-title":"Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts","volume":"21","author":"Kerbel","year":"1974","journal-title":"Biomedicine"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0285","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.4110\/in.2020.20.e4","article-title":"Regulatory t cells in tumor microenvironment and approach for anticancer immunotherapy","volume":"20","author":"Kim","year":"2020","journal-title":"Immune Netw."},{"issue":"March","key":"10.1016\/j.critrevonc.2021.103226_bib0290","first-page":"1","article-title":"Rationale for IL-15 superagonists in cancer immunotherapy","volume":"11","author":"Knudson","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0295","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000069313","article-title":"A pilot phase II study of capecitabine in advanced or recurrent gastric cancer","volume":"64","author":"Koizumi","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0300","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/1097-0142(20000915)89:6<1380::AID-CNCR23>3.0.CO;2-R","article-title":"Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis","volume":"89","author":"Kotsakis","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0305","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/cam4.638","article-title":"Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapy","volume":"5","author":"Kou","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00001813-200203000-00001","article-title":"Amifostine in clinical oncology: current use and future applications","volume":"13","author":"Koukourakis","year":"2002","journal-title":"Anticancer Drugs"},{"issue":"May","key":"10.1016\/j.critrevonc.2021.103226_bib0315","first-page":"22","article-title":"Tumor microenvironment, immune response and post-radiotherapy tumor clearance","author":"Koukourakis","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0320","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0360-3016(98)00370-8","article-title":"Concurrent twice-a-week docetaxel and radiotherapy: a dose-escalation trial with immunological toxicity evaluation","volume":"43","author":"Koukourakis","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0325","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00262-002-0342-y","article-title":"Amifostine protects lymphocytes during radiotherapy and stimulates the expansion of the CD95\/Fas and CD31 expressing T-cells, in breast cancer patients","volume":"52","author":"Koukourakis","year":"2003","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0330","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/09553000802635070","article-title":"Amifostine enhances recovery and expansion of peripheral FAS\/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer","volume":"85","author":"Koukourakis","year":"2009","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0335","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1158\/1078-0432.CCR-14-1138","article-title":"Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response","volume":"20","author":"Kuo","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0340","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41416-019-0559-6","article-title":"Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer","volume":"121","author":"Kuwahara","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0345","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI105164","article-title":"The net balance of acid in subjects given large loads of acid or alakali","volume":"44","author":"Lemann","year":"1965","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0350","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.fct.2009.06.042","article-title":"Cytoprotective activity of amifostine on cultured human lymphocytes exposed to irinotecan","volume":"47","author":"Lialiaris","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0355","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13014-017-0824-x","article-title":"Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma","volume":"12","author":"Liu","year":"2017","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4143\/crt.2016.595","article-title":"The prognostic value of treatment-related lymphopenia in nasopharyngeal carcinoma patients","volume":"50","author":"Liu","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0365","article-title":"A multi-institutional comparative analysis of proton and photon therapy-induced hematologic toxicity in patients with medulloblastoma","author":"Liu","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0370","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/SLA.0b013e3181fd271c","article-title":"A lethally irradiated allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation","volume":"253","author":"Lutz","year":"2011","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0375","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/1097-0142(197801)41:1<108::AID-CNCR2820410116>3.0.CO;2-Z","article-title":"Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation","volume":"41","author":"MacLennan","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0380","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cncr.30601","article-title":"A multi institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck","volume":"123","author":"Manyam","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0385","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/bjc.2012.58","article-title":"Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study","volume":"106","author":"Martin","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0390","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0395","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines?","volume":"7","author":"M\u00e9n\u00e9trier-Caux","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0400","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1158\/1078-0432.CCR-15-2550","article-title":"Adjuvant immunotherapy to improve outcome in high-risk pediatric sarcomas","volume":"22","author":"Merchant","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0405","article-title":"Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs. photons","author":"Mohan","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0410","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0360-3016(01)01710-2","article-title":"Alteration of radiation-induced hematotoxicity by amifostine","volume":"51","author":"Momm","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0415","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.radonc.2015.10.029","article-title":"Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy","volume":"118","author":"Moon","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"August","key":"10.1016\/j.critrevonc.2021.103226_bib0420","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00066-004-1216-3","article-title":"Radioprotective effects of amifostine in vitro and in vivo measured with the comet assay","volume":"180","author":"M\u00fcller","year":"2004","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0425","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000225550","article-title":"Hematologic effects of cis-platinum-bleomycin therapy","volume":"38","author":"Najarian","year":"1981","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0430","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.12.023","article-title":"Lymphopenia during radiotherapy in patients with oropharyngeal cancer","volume":"145","author":"Ng","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0435","doi-asserted-by":"crossref","first-page":"C569","DOI":"10.1152\/ajpcell.00207.2015","article-title":"Hypoxia: a key player in anti-tumor immune response. A review in the theme: cellular responses to hypoxia","volume":"309","author":"Noman","year":"2015","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0440","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O\u2019Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0445","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1158\/1078-0432.CCR-18-1038","article-title":"Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation and regulatory T-cell infiltration","volume":"24","author":"Oweida","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0450","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11060-017-2678-3","article-title":"Pre-treatment lymphopenia and indication of tumor-induced systemic immunosuppression in medulloblastoma","volume":"136","author":"Patel","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0455","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10549-018-05106-7","article-title":"Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer","volume":"174","author":"Patel","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0460","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0465","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2015.02.023","article-title":"Survival fraction at 2 Gy and \u03b3H2AX expression kinetics in peripheral blood lymphocytes from cancer patients: relationship with acute radiation-induced toxicities","volume":"92","author":"Pouliliou","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0470","first-page":"234","article-title":"Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes","volume":"7","author":"Prieto Gonz\u00e1lez","year":"2009","journal-title":"Dose Response"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0475","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0024-3205(99)00096-X","article-title":"In vivo amifostine (WR-2721) prevents chemotherapy-induced apoptosis of peripheral blood lymphocytes from cancer patients","volume":"64","author":"Provinciali","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0480","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.neo.7900151","article-title":"Acute metabolic alkalosis enhances the response of C3H mouse mammary tumors to the weak base mitoxantrone","volume":"3","author":"Raghunand","year":"2001","journal-title":"Neoplasia"},{"issue":"Suppl. 3","key":"10.1016\/j.critrevonc.2021.103226_bib0485","doi-asserted-by":"crossref","first-page":"E206","DOI":"10.1016\/j.ijrobp.2015.07.1071","article-title":"Immunocompromised patients with prostate cancer treated with external beam radiation: a matched pair analysis","volume":"93","author":"Ramey","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0490","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","article-title":"Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas","volume":"69","author":"Ray-Coquard","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0495","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.2147\/CMAR.S190084","article-title":"A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate","volume":"11","author":"Reed","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2021.103226_bib0500","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/pbc.22409","article-title":"Feasibility and tolerability of bevacizumab in children with primary CNS tumors","volume":"54","author":"Reism\u00fcller","year":"2010","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0505","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-07-5575","article-title":"Bicarbonate increases tumor pH and inhibits spontaneous metastases","volume":"69","author":"Robey","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0510","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.cji.0000210386.55951.c2","article-title":"IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells","volume":"29","author":"Rosenberg","year":"2006","journal-title":"J Immunother."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0515","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.adro.2018.09.004","article-title":"A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer","volume":"4","author":"Routman","year":"2019","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0520","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1269\/jrr.10030","article-title":"Amifostine modulates radio-induced apoptosis of peripheral blood lymphocytes in head and neck cancer patients","volume":"51","author":"Saavedra","year":"2010","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0525","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1349-7006.1988.tb00020.x","article-title":"Three schedules of recombinant human interleukin-2 in the treatment of malignancy: side effects and immunologic effects in relation to serum level","volume":"79","author":"Sano","year":"1988","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0530","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.adro.2019.01.005","article-title":"Radiation-related lymphopenia after pelvic nodal irradiation for prostate cancer","volume":"4","author":"Schad","year":"2019","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0535","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.leukres.2009.03.027","article-title":"Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes","volume":"33","author":"Schanz","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0540","first-page":"175","article-title":"Immunogenetic studies on the resistance of mice to highly metastatic DBA\/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction, and cytotoxic response","volume":"1","author":"Schirrmacher","year":"1981","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0545","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1084\/jem.20061104","article-title":"Phosphodiesterase-5 inhibition augments endogenous anti-tumor immunity by reducing myeloid-derived suppressor cell function","volume":"203","author":"Serafini","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0550","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s002620050577","volume":"48","author":"Setti","year":"1999","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0555","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1470-2045(17)30380-7","article-title":"Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial","volume":"18","author":"Shaverdian","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0560","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2017.11.028","article-title":"Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: a propensity matched analysis of the relative risk of proton versus photon-based radiation therapy","volume":"128","author":"Shiraishi","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0565","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00205454","article-title":"Immunodeficiency in cancer patients and immunorestoration","volume":"1","author":"Simmler","year":"1976","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0570","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijrobp.2015.01.011","article-title":"Combination effect of regulatory T-cell depletion and ionizing radiation in mouse models of lung and colon cancer","volume":"92","author":"Son","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0575","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/198110a0","article-title":"Immunological tolerance, infective tolerance and virus-induced neoplastic transformation","volume":"198","author":"Stansly","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0580","first-page":"1229","article-title":"Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma","volume":"63","author":"Stone","year":"1979","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0585","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(197007)26:1<232::AID-CNCR2820260129>3.0.CO;2-D","article-title":"Immunologic status of host and response of a methylcholanthrene-induced sarcoma to local x-irradiation","volume":"26","author":"Suit","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0590","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0360-3016(90)90102-P","article-title":"Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report","volume":"18","author":"Suit","year":"1990","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0595","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejca.2017.07.033","article-title":"Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1\/PD-L1 inhibitors)","volume":"84","author":"Sun","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0600","doi-asserted-by":"crossref","first-page":"e126853","DOI":"10.1172\/jci.insight.126853","article-title":"Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy","volume":"4","author":"Sun","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0605","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2020.02.633","article-title":"Radiation-induced lymphopenia predicts poorer prognosis in patients with breast cancer: a post hoc analysis of a randomized controlled trial of postmastectomy hypofractionated radiation therapy","volume":"108","author":"Sun","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0610","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ijrobp.2019.03.041","article-title":"Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma","volume":"104","author":"Sundahl","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0615","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cllc.2018.11.013","article-title":"Prognostic significance of total lymphocyte count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in limited-stage small-cell lung cancer","volume":"20","author":"Suzuki","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0620","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0099","article-title":"The chemistry, physiology and pathology of pH in cancer","volume":"369","author":"Swietach","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0625","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0630","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/1097-0142(197503)35:3<638::AID-CNCR2820350315>3.0.CO;2-O","article-title":"Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapy","volume":"35","author":"Tarpley","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0635","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/annonc\/mdv173","article-title":"ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients","volume":"26","author":"Tredan","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0640","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2018.05.075","article-title":"Effect of patient immune status on the efficacy of radiation therapy and recurrence-free survival among 805 patients with merkel cell carcinoma","volume":"102","author":"Tseng","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0645","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0650","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0655","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(98)07186-4","article-title":"Active specific immunotherapy for stage II and stage III human colon cancer: a randomized trial","volume":"353","author":"Vermorken","year":"1999","journal-title":"Lancet."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0660","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2249.2005.02859.x","article-title":"Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis","volume":"141","author":"Vigna-P\u00e9rez","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0665","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MPH.0000000000001348","article-title":"Oral methods of urinary alkalinization for high-dose methotrexate administration: alternatives to intravenous sodium bicarbonate during a critical drug shortage","volume":"41","author":"Visage","year":"2019","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0670","doi-asserted-by":"crossref","first-page":"e0155218","DOI":"10.1371\/journal.pone.0155218","article-title":"The impact of azathioprine-associated lymphopenia on the onset of opportunistic infections in patients with inflammatory bowel disease","volume":"11","author":"V\u00f6gelin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0675","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41590-019-0429-7","article-title":"Connecting blood and intratumoral T(reg) cell activity in predicting future relapse in breast cancer","volume":"20","author":"Wang","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0680","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1078-0432.CCR-14-1711","article-title":"Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma","volume":"21","author":"Weed","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0685","first-page":"585","article-title":"Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses","volume":"28","author":"Wei","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0690","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1158\/1078-0432.CCR-16-0127","article-title":"Baseline biomarkers for outcome of melanoma patients treated with pembrolizumab","volume":"22","author":"Weide","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0695","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s002620000159","article-title":"Granulocyte\/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon alpha in the treatment of metastatic renal cell carcinoma: a pilot study","volume":"49","author":"Westermann","year":"2001","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0700","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pharmthera.2016.04.009","article-title":"Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer","volume":"164","author":"Wigerup","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0705","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2015.11.026","article-title":"Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer","volume":"94","author":"Wild","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0710","first-page":"22","article-title":"Amifostine can differentially modulate DNA double-strand breaks and apoptosis induced by idarubicin in normal and cancer cells","volume":"30","author":"Wozniak","year":"2008","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0715","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10637-016-0411-2","article-title":"Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors","volume":"35","author":"Yamamoto","year":"2017","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.critrevonc.2021.103226_bib0720","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s10147-018-1374-4","article-title":"Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer","volume":"24","author":"Yoshino","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0725","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s12094-018-1851-2","article-title":"Comparative analysis of the effect of different radiotherapy regimes on lymphocyte and its subpopulations in breast cancer patients","volume":"20","author":"Yuan","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0730","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9691067","article-title":"Lymphopenia is associated with gross target volumes and fractions in hepatocellular carcinoma patients treated with external beam radiation therapy and also indicates worse overall survival","volume":"2019","author":"Zhang","year":"2019","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.critrevonc.2021.103226_bib0735","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-019-1287-z","article-title":"Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC","volume":"14","author":"Zhao","year":"2019","journal-title":"Radiat. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:39:43Z","timestamp":1760902783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842821000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":147,"alternative-id":["S1040842821000147"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103226","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103226"}}